SEARCH

SEARCH BY CITATION

References

  • Andreasen N. C., Endicott J., Spitzer R. L. and Winokur G. (1977) Family history method using diagnostic criteria: reliability and validity. Arch. Gen. Psychiatry 34, 12291235.
  • Beck A. T., Ward C. H., Mendelson M., Mock J. and Erbaugh J. (1961) An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561571.
  • Berney A., Nishikawa M., Benkelfat C., Debonnel G., Gobbi G. and Diksic M. (2008) An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochem. Int. 52, 701708.
  • Berney A., Leyton M., Gravel P. et al. (2011) Brain regional alpha-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry 68, 732741.
  • Biezonski D. K. and Meyer J. S. (2011) The nature of 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonergic dysfunction: evidence for and against the neurodegeneration hypothesis. Curr. Neuropharmacol. 9, 8490.
  • Boileau I., Dagher A., Leyton M., Gunn R. N., Baker G. B., Diksic M. and Benkelfat C. (2006) Modeling sensitization to stimulants in humans: an [11C] raclopride/positron emission tomography study in healthy men. Arch. Gen. Psychiatry 63, 13861395.
  • Bonkale W. L. and Austin M. C. (2008) 3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus. Neuroscience 155, 270276.
  • Booij L., Tremblay R. E., Leyton M. et al. (2010) Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study. PLoS ONE 5, e11255.
  • Booij L., Turecki G., Leyton M., Gravel P., De Lara C. L., Diksic M. and Benkelfat C. (2012) Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol. Psychiatry 17, 809817.
  • Bremner J. D., Innis R. B., Salomon R. M. et al. (1997) Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry 54, 364374.
  • Buchert R., Thomasius R., Petersen K., Wilke F., Obrocki J., Nebeling B., Wartberg L., Zapletalova P. and Clausen M. (2006) Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users. Eur. J. Nucl. Med. Mol. Imaging 33, 188199.
  • Capela J. P., Carmo H., Remiao F., Bastos M. L., Meisel A. and Carvalho F. (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 39, 210271.
  • Collins D. L., Neelin P., Peters T. M. and Evans A. C. (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192205.
  • Collins D. L., Zijdenbos A. P., Baare W. F. C. and Evans A. C. (1999) ANIMAL+INSECT: improved cortical structure segmentation, in Information Processing in Medical Imaging: 16th International Conference, IPMI'99 Visegrád, Hungary, June 28 – July 2, 1999 Proceedings (Kuba A., Samal M. and Todd-Pokropek A., eds), pp. 210223. Springer, Berlin Heidelberg.
  • Di Iorio C. R., Watkins T. J., Dietrich M. S. et al. (2012) Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch. Gen. Psychiatry 69, 399409.
  • Diksic M. and Young S. N. (2001) Study of the brain serotonergic system with labeled alpha-methyl-L-tryptophan. J. Neurochem. 78, 11851200.
  • Faul F., Erdfelder E., Lang A. G. and Buchner A. (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175191.
  • First M. B., Spitzer R. L., Gibbon M. and Williams J. B. W. (2002) Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID I/P). Biometrics Research, New York State Psychiatric Institute, New York.
  • Hatzidimitriou G., McCann U. D. and Ricaurte G. A. (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J. Neurosci. 19, 50965107.
  • Jang M. H., Shin M. C., Lee T. H. et al. (2002) Alcohol and nicotine administration inhibits serotonin synthesis and tryptophan hydroxylase expression in dorsal and median raphe of young rats. Neurosci. Lett. 329, 141144.
  • Johnston L. D., O'Malley P. M., Bachman J. G. and Schulenberg J. E. (2011) Monitoring the Future: National Survey Results on Drug Use, 1975–2010: Volume II, College Students and Adults Ages 19–50. Institute for Social Research, The University of Michigan, Ann Arbor.
  • Johnston L., O'Malley P., Bachman J. and Schulenberg J. E. (2012) Monitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings, 2011. Institute for Social Research, The University of Michigan, Ann Arbor.
  • Krul J., Girbes A. R. J. and Sanou B. T. (2012) Increase in serious ecstasy-related incidents in the Netherlands. Lancet 380, 1385.
  • Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., Mzengeza S., Young S. N., Blier P. and Benkelfat C. (2001) Brain regional alpha-[C-11]Methyl-(L)-tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 158, 775782.
  • Leyton M., Diksic M. and Benkelfat C. (2005) Brain regional alpha-[11C]methyl-L-tryptophan trapping correlates with post-mortem tissue serotonin content and [11C]5-hydroxytryptophan accumulation. Int. J. Neuropsychopharmacol. 8, 633634.
  • Lundquist P., Hartvig P., Blomquist G., Hammarlund-Udenaes M. and Langstrom B. (2007) 5-Hydroxy-L-[beta-11C]tryptophan versus alpha-[11C]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain. J. Cereb. Blood Flow Metab. 27, 821830.
  • McCann U. D., Ridenour A., Shaham Y. and Ricaurte G. A. (1994) Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; “Ecstasy”): a controlled study in humans. Neuropsychopharmacology 10, 129138.
  • McCann U. D., Eligulashvili V., Mertl M., Murphy D. L. and Ricaurte G. A. (1999) Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology 147, 5665.
  • Molliver M. E., Berger U. V., Mamounas L. A., Molliver D. C., Ohearn E. and Wilson M. A. (1990) Neurotoxicity of MDMA and related-compounds: anatomic studies. Ann. N. Y. Acad. Sci. 600, 640664.
  • Muck-Seler D., Takahashi S. and Diksic M. (1998) The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study. Brain Res. 810, 7686.
  • Mueller M., Yuan J., McCann U. D., Hatzidimitriou G. and Ricaurte G. A. (2013) Single oral doses of (+/-) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations. Int. J. Neuropsychopharmacol. 16, 791801.
  • Neumeister A., Nugent A. C., Waldeck T. et al. (2004) Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch. Gen. Psychiatry 61, 765773.
  • Nishikawa M., Diksic M., Sakai Y., Kumano H., Charney D., Palacios-Boix J., Negrete J. and Gill K. (2009) Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography. Alcohol. Clin. Exp. Res. 33, 233239.
  • Nishizawa S., Benkelfat C., Young S. N., Leyton M., Mzengeza S., de Montigny C., Blier P. and Diksic M. (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl Acad. Sci. USA 94, 53085313.
  • Nishizawa S., Leyton M., Okazawa H., Benkelfat C., Mzengeza S. and Diksic M. (1998) Validation of a less-invasive method for measurement of serotonin synthesis rate with alpha-[11C]methyl-tryptophan. J. Cereb. Blood Flow Metab. 18, 11211129.
  • Okazawa H. and Diksic M. (1998) Image generation of serotonin synthesis rates using alpha-methyltryptophan and PET. J. Comput. Assist. Tomogr. 22, 777785.
  • Parrott A. C. (2013) MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users. Neurosci. Biobehav. Rev. 37, 14661484.
  • Reneman L., Majoie C. B. L. M., Habraken J. B. A. and den Heeten G. J. (2001) Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology 220, 611617.
  • Rogers G., Elston J., Garside R., Roome C., Taylor R., Younger P., Zawada A. and Somerville M. (2009) The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol. Assess. 13, 1315.
  • Rosa-Neto P., Diksic M., Okazawa H. et al. (2004) Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch. Gen. Psychiatry 61, 556563.
  • Rosa-Neto P., Diksic M., Leyton M., Mzengeza S. and Benkelfat C. (2005) Stability of alpha-[11C] methyl-L-tryptophan brain trapping in healthy male volunteers. Eur. J. Nucl. Med. Mol. Imaging 32, 11991204.
  • Rosa-Neto P., Benkelfat C., Sakai Y., Leyton M., Morais J. A. and Diksic M. (2007) Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect. Eur. J. Nucl. Med. Mol. Imaging 34, 12541264.
  • Sakai Y., Nishikawa M., Leyton M., Benkelfat C., Young S. N. and Diksic M. (2006) Cortical trapping of alpha-[11C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 33, 815824.
  • Scheffel U., Szabo Z., Mathews W. B., Finley P. A., Dannals R. F., Ravert H. T., Szabo K., Yuan J. and Ricaurte G. A. (1998) In vivo detection of short- and long-term MDMA neurotoxicity-a positron emission tomography study in the living baboon brain. Synapse 29, 183192.
  • Shen E. Y., Ali S. F. and Meyer J. S. (2011) Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacology 61, 11831192.
  • Shoaf S. E., Carson R., Hommer D., Williams W., Higley J. D., Schmall B., Herscovitch P., Eckelman W. and Linnoila M. (1998) Brain serotonin synthesis rates in rhesus monkeys determined by [11C]alpha-methyl-L-tryptophan and positron emission tomography compared to CSF 5-hydroxyindole-3-acetic acid concentrations. Neuropsychopharmacology 19, 345353.
  • Smith K. A., Morris J. S., Friston K. J., Cowen P. J. and Dolan R. J. (1999) Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br. J. Psychiatry 174, 525529.
  • Urban N. B., Girgis R. R., Talbot P. S. et al. (2012) Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [11C]DASB and [11C]MDL 100907. Neuropsychopharmacology 37, 14651473.
  • Walker Q. D., Williams C. N., Jotwani R. P., Waller S. T., Francis R. and Kuhn C. M. (2007) Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. Psychopharmacology 189, 435445.
  • Woods R. P., Mazziotta J. C. and Cherry S. R. (1993) MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17, 536546.
  • Young S., Regoli M., Leyton M., Pihl R. and Benkelfat C. (2014) The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstacy users. Psychopharmacology 231, 707716.
  • Yuki F., Rie I., Miki K., Mitsuhiro W., Naotaka K. and Kenichiro N. (2013) Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain. Eur. J. Pharm. Sci. 49, 5764.